Page last updated: 2024-11-01

nitrendipine and Brain Neoplasms

nitrendipine has been researched along with Brain Neoplasms in 2 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ween, H1
Thorin-Hagene, K1
Andersen, E1
Grønlien, JH1
Lee, CH1
Gopalakrishnan, M1
Malysz, J1
Saqr, HE1
Guan, Z1
Yates, AJ1
Stokes, BT1

Other Studies

2 other studies available for nitrendipine and Brain Neoplasms

ArticleYear
Alpha3* and alpha 7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells.
    Neurochemistry international, 2010, Volume: 57, Issue:3

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Benzamides; Brain Neoplasms; Bridged Bicyclo Compounds; Cal

2010
Mechanisms through which PDGF alters intracellular calcium levels in U-1242 MG human glioma cells.
    Neurochemistry international, 1999, Volume: 35, Issue:6

    Topics: Becaplermin; Brain Neoplasms; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium

1999